The CJC-1295 w/o DAC 5 mg + Ipamorelin 5 mg combination is utilized in endocrine and receptor-binding research models examining peptide interactions within growth hormone–releasing pathways.
CJC-1295 (CAS 863288-34-0) is a synthetic analog of growth hormone–releasing hormone (GHRH) that has been studied for its stability and receptor selectivity.
Ipamorelin (CAS 170851-70-4) is a pentapeptide explored for its activity at ghrelin and GHRP receptors in controlled cell-based assays.
Researchers use this dual-peptide set to study peptide synergy, receptor response kinetics, and downstream cellular signaling in experimental settings.
Molecular Formula:
CJC-1295 – C152H252N44O42
Ipamorelin – C38H49N9O5
CAS: 863288-34-0 / 170851-70-4
Approx. Combined MW: ~4079 g/mol
For Research Use Only – Not for Human Consumption.
Reviews
There are no reviews yet.